U.S.C. Section 1350,
ADOPTED PURSUANT TO
906 OF THE SARBANES-OXLEY ACT OF 2002
connection with the Quarterly Report of Oragenics, Inc. (the "Company") on Form
10-Q for the period ended March 31, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, David B. Hirsch,
Acting Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
information contained in this Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
original of this written certification has been provided to the company and will
be retained by the company and furnished to the Securities and Exchange
Commission or its staff upon request.
this 20th day of
Chief Executive Officer